A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg
Clinical trial NCT00464308 · COMPLETED
Trial details
- NCT number
- NCT00464308
- Sponsor
- Janssen-Cilag Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2008-05-01
- Enrollment
- 1392
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.